Swiss National Bank boosted its stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 3.0% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 731,316 shares of the medical equipment provider’s stock after buying an additional 21,600 shares during the period. Swiss National Bank owned approximately 0.36% of Zimmer Biomet Holdings worth $93,901,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of ZBH. Profund Advisors LLC increased its position in shares of Zimmer Biomet Holdings by 12.0% in the first quarter. Profund Advisors LLC now owns 8,093 shares of the medical equipment provider’s stock worth $988,000 after buying an additional 867 shares during the period. Strs Ohio increased its position in shares of Zimmer Biomet Holdings by 13.5% in the first quarter. Strs Ohio now owns 12,865 shares of the medical equipment provider’s stock worth $1,570,000 after buying an additional 1,532 shares during the period. iAB Financial Bank increased its position in shares of Zimmer Biomet Holdings by 7.5% in the first quarter. iAB Financial Bank now owns 5,375 shares of the medical equipment provider’s stock worth $656,000 after buying an additional 375 shares during the period. Selway Asset Management increased its position in shares of Zimmer Biomet Holdings by 0.5% in the first quarter. Selway Asset Management now owns 36,840 shares of the medical equipment provider’s stock worth $4,499,000 after buying an additional 200 shares during the period. Finally, Decatur Capital Management Inc. increased its position in shares of Zimmer Biomet Holdings by 128.1% in the first quarter. Decatur Capital Management Inc. now owns 86,521 shares of the medical equipment provider’s stock worth $10,565,000 after buying an additional 48,587 shares during the period. Hedge funds and other institutional investors own 85.47% of the company’s stock.

Shares of Zimmer Biomet Holdings, Inc. (NYSE ZBH) opened at 114.33 on Friday. Zimmer Biomet Holdings, Inc. has a 52 week low of $95.63 and a 52 week high of $133.49. The firm has a market capitalization of $23.12 billion, a PE ratio of 32.56 and a beta of 1.21. The firm’s 50-day moving average is $118.83 and its 200 day moving average is $120.82.

Zimmer Biomet Holdings (NYSE:ZBH) last announced its earnings results on Thursday, July 27th. The medical equipment provider reported $2.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.10 by $0.02. The business had revenue of $1.95 billion for the quarter, compared to analysts’ expectations of $1.95 billion. Zimmer Biomet Holdings had a return on equity of 16.70% and a net margin of 9.12%. The business’s revenue was up 1.1% on a year-over-year basis. During the same quarter last year, the business posted $2.02 earnings per share. On average, equities analysts forecast that Zimmer Biomet Holdings, Inc. will post $8.24 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Friday, September 22nd will be issued a dividend of $0.24 per share. This represents a $0.96 annualized dividend and a dividend yield of 0.84%. The ex-dividend date of this dividend is Thursday, September 21st. Zimmer Biomet Holdings’s dividend payout ratio is presently 27.59%.

COPYRIGHT VIOLATION NOTICE: This story was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this story on another site, it was stolen and republished in violation of U.S. & international copyright legislation. The legal version of this story can be read at https://www.thecerbatgem.com/2017/09/02/swiss-national-bank-has-93-90-million-stake-in-zimmer-biomet-holdings-inc-zbh.html.

A number of analysts have commented on the stock. Stifel Nicolaus reaffirmed a “hold” rating and set a $125.00 target price on shares of Zimmer Biomet Holdings in a report on Friday, July 14th. Gabelli assumed coverage on shares of Zimmer Biomet Holdings in a report on Thursday, August 24th. They set a “buy” rating and a $142.00 target price for the company. Zacks Investment Research cut shares of Zimmer Biomet Holdings from a “hold” rating to a “strong sell” rating in a report on Tuesday, August 8th. BMO Capital Markets reaffirmed a “buy” rating and set a $136.00 target price on shares of Zimmer Biomet Holdings in a report on Tuesday, July 11th. Finally, Wells Fargo & Company reissued a “market weight” rating on shares of Zimmer Biomet Holdings in a research note on Friday, July 14th. Four investment analysts have rated the stock with a sell rating, seven have assigned a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus price target of $136.75.

In other Zimmer Biomet Holdings news, insider Sang Yi sold 17,731 shares of the firm’s stock in a transaction on Monday, June 12th. The stock was sold at an average price of $124.56, for a total value of $2,208,573.36. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Tony W. Collins sold 16,986 shares of the firm’s stock in a transaction on Monday, July 31st. The shares were sold at an average price of $121.74, for a total value of $2,067,875.64. The disclosure for this sale can be found here. 1.07% of the stock is owned by company insiders.

About Zimmer Biomet Holdings

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Want to see what other hedge funds are holding ZBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zimmer Biomet Holdings, Inc. (NYSE:ZBH).

Institutional Ownership by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

Receive News & Stock Ratings for Zimmer Biomet Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc. and related stocks with our FREE daily email newsletter.